T1	Participants 13 51	patients with small choroidal melanoma
T2	Participants 439 479	medium and large-size choroidal melanoma
T3	Participants 516 616	patients with small choroidal melanoma, not large enough to be eligible for the COMS clinical trials
T4	Participants 816 828	204 patients
T5	Participants 1499 1656	Otherwise healthy patients, average age of 60 years, without a previous diagnosis of malignant disease who have small choroidal lesions judged to be melanoma
